Literature DB >> 34970513

Results From the WAGR Syndrome Patient Registry: Characterization of WAGR Spectrum and Recommendations for Care Management.

Kelly A Duffy1, Kelly L Trout2, Jennifer M Gunckle2, Shari McCullen Krantz2, John Morris2, Jennifer M Kalish1,3.   

Abstract

WAGR syndrome is a rare genetic disorder characterized by Wilms tumor, Aniridia, Genitourinary anomalies, and Range of developmental delays. In addition to the classic features, patients affected by WAGR syndrome can develop obesity and kidney failure, and a wide variety of non-classical manifestations have also been described. This suggests that a broader phenotypic spectrum beyond the classic syndrome exists and here we demonstrate that spectrum using data from the WAGR Syndrome Patient Registry. In the present study, we collected information from 91 individuals enrolled in the registry to explore self-reported health issues in this patient population. A wide variety of common clinical issues not classically associated with the disorder were found, prompting the redefinition from WAGR syndrome to WAGR spectrum disorder to incorporate the phenotypic variations that occur. A comprehensive care management approach is needed to address the wide range of clinical issues and we propose a care model for patients affected by WAGR spectrum disorder. Further research is needed to solidify the breath of the phenotype and confirm the observations in this study to advance individualized patient care in this population.
Copyright © 2021 Duffy, Trout, Gunckle, Krantz, Morris and Kalish.

Entities:  

Keywords:  11p13 deletion; Aniridia; Genitourinary anomalies; WAGR syndrome (Wilms tumor; and range of developmental delays); rare disease registry

Year:  2021        PMID: 34970513      PMCID: PMC8712693          DOI: 10.3389/fped.2021.733018

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  69 in total

1.  Morbid obesity and hyperphagia in the WAGR syndrome.

Authors:  David J Amor
Journal:  Clin Dysmorphol       Date:  2002-01       Impact factor: 0.816

2.  Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group.

Authors:  Peter F Ehrlich; Yueh-Yun Chi; Murali M Chintagumpala; Fredric A Hoffer; Elizabeth J Perlman; John A Kalapurakal; Brett Tornwall; Anne Warwick; Robert C Shamberger; Geetika Khanna; Thomas E Hamilton; Kenneth W Gow; Arnold C Paulino; Eric J Gratias; Elizabeth A Mullen; James I Geller; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome
Journal:  Cancer       Date:  2020-05-27       Impact factor: 6.860

3.  Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management.

Authors:  Kelly A Duffy; Christopher M Cielo; Jennifer L Cohen; Christina X Gonzalez-Gandolfi; Jessica R Griff; Evan R Hathaway; Jonida Kupa; Jesse A Taylor; Kathleen H Wang; Arupa Ganguly; Matthew A Deardorff; Jennifer M Kalish
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-08-30       Impact factor: 3.908

4.  The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Michael G Shlipak; Sri Lekha Tummalapalli; L Ebony Boulware; Morgan E Grams; Joachim H Ix; Vivekanand Jha; Andre-Pascal Kengne; Magdalena Madero; Borislava Mihaylova; Navdeep Tangri; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Sophia Zoungas
Journal:  Kidney Int       Date:  2020-10-27       Impact factor: 10.612

5.  Bezafibrate to prevent relapsing pancreatitis in WAGR syndrome.

Authors:  Daniela Diacono; Andrew Fagbemi; Joanne Puleston; Indraneel Banerjee
Journal:  BMJ Case Rep       Date:  2012-11-14

6.  Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Authors:  Paul E Stevens; Adeera Levin
Journal:  Ann Intern Med       Date:  2013-06-04       Impact factor: 25.391

7.  Brain-derived neurotrophic factor and obesity in the WAGR syndrome.

Authors:  Joan C Han; Qing-Rong Liu; MaryPat Jones; Rebecca L Levinn; Carolyn M Menzie; Kyra S Jefferson-George; Diane C Adler-Wailes; Ethan L Sanford; Felicitas L Lacbawan; George R Uhl; Owen M Rennert; Jack A Yanovski
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

8.  Association of brain-derived neurotrophic factor (BDNF) haploinsufficiency with lower adaptive behaviour and reduced cognitive functioning in WAGR/11p13 deletion syndrome.

Authors:  Joan C Han; Audrey Thurm; Christine Golden Williams; Lisa A Joseph; Wadih M Zein; Brian P Brooks; John A Butman; Sheila M Brady; Shannon R Fuhr; Melanie D Hicks; Amanda E Huey; Alyson E Hanish; Kristen M Danley; Margarita J Raygada; Owen M Rennert; Keri Martinowich; Stephen J Sharp; Jack W Tsao; Susan E Swedo
Journal:  Cortex       Date:  2013-02-19       Impact factor: 4.027

9.  11p Microdeletion including WT1 but not PAX6, presenting with cataract, mental retardation, genital abnormalities and seizures: a case report.

Authors:  Gitte J Almind; Karen Brøndum-Nielsen; Regitze Bangsgaard; Peter Baekgaard; Karen Grønskov
Journal:  Mol Cytogenet       Date:  2009-02-17       Impact factor: 2.009

Review 10.  The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?

Authors:  Yarden S Fraiman; Monica H Wojcik
Journal:  Pediatr Res       Date:  2020-09-15       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.